NMIN
PRESS RELEASES
Canadian scientist awarded international prize for COVID vaccine technology
Canadian scientist Dr. Pieter Cullis, together with his peers Drs Katalin Kariko and Drew Weissman, have been honoured with the 2021 Prince Mahidol Award for their contributions to the development of COVID-19 messenger RNA (mRNA) vaccines.
NMIN names new Scientific Director & CEO Dr. Christine Allen
The NanoMedicines Innovation Network (NMIN), a national research network funded by the Government of Canada, has appointed Dr. Christine Allen Scientific Director & CEO, effective 1 July 2021.
Canadian technology enables Pfizer’s promising COVID-19 vaccine
Pfizer has caught the world’s attention with its promising early results for a COVID-19 vaccine candidate. What has been less widely publicized is the pivotal role of Canadian know-how and technology in the development of this potential vaccine.
VANCOUVER, BC (12 November 2020)
Gene therapy enabled by nanotechnology: A new era of medicine
NanoMedicines Innovation Network (NMIN) thought leaders contribute to a commentary in the December 2019 issue of Nature Nanotechnology
VANCOUVER, BC (4 December 2019)